{
    "code": "06015371",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06015371",
    "time": "2020-11-27 06:30:29",
    "許可證字號": "衛署醫器輸字第015371號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD1489",
    "有效日期": "114\/12\/09",
    "發證日期": "94\/12\/09",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00601537100",
    "中文品名": "&quot;西門子&quot;卡巴馬平試劑組",
    "英文品名": "&quot;SIEMENS&quot; Carbamazepine (CARB)",
    "效能": "配合\"拜耳\"全自動冷光免疫分析系統，定量檢測血清或血漿中的卡巴馬平(carbamazepine)。",
    "醫器規格": "#119933: 250 tests, #119932: 50 tests, #107581: 300 tests, #107582: 50 tests, #05163003: 250 tests, #05162724: 50 tests。\r\n註銷規格：#119933：250tests、 #119932：50tests、#107581：300tests、#107582：50tests(原94年12月28日核定之仿單標籤核定本予以作廢)。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A3645致類神經病狀的放射性受體分析試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "6203282380  西門子醫療設備股份有限公司",
    "申請商地址": "台北市南港區園區街3號2樓之2",
    "主製造廠": [
        {
            "製造廠名稱": "MUS1176000  SIEMENS HEALTHCARE DIAGNOSTICS INC.",
            "製造廠廠址": "333 CONEY ST. EAST WALPOLE, MA 02032, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "060153710002-103-06-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06015371&Seq=001&Type=9"
        },
        {
            "title": "060153710001-103-06-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06015371&Seq=001&Type=8"
        }
    ]
}